{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:01:34Z","timestamp":1778673694947,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clinme.2024.100265","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:17:06Z","timestamp":1730971026000},"page":"100265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Staphylococcus aureus bacteraemia for the general physician: A narrative review of a metastatic infection with malignant complications"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-6376","authenticated-orcid":false,"given":"Ronak J.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8008-4835","authenticated-orcid":false,"given":"Ioannis","family":"Baltas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2024.100265_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia\u2013a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.clinme.2024.100265_bib0002","unstructured":"UK Health Security Agency, Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2022 to 2023, (2024). https:\/\/www.gov.uk\/government\/statistics\/mrsa-mssa-and-e-coli-bacteraemia-and-c-difficile-infection-annual-epidemiological-commentary\/annual-epidemiological-commentary-gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-up-to-and-including-financial-year-2022-to-2023 (Accessed June 10, 2024)."},{"key":"10.1016\/j.clinme.2024.100265_bib0003","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","article-title":"MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis","volume":"6","author":"Singhal","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.clinme.2024.100265_bib0004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/antibiotics11020239","article-title":"Detection of methicillin-resistant Staphylococcus aureus infections using molecular methods","volume":"11","author":"Tenover","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.clinme.2024.100265_bib0005","unstructured":"Public Health England. PVL-Staphylococcus aureus infections: diagnosis and management. (2008)."},{"key":"10.1016\/j.clinme.2024.100265_bib0006","series-title":"Quality of Care Indicators For the Management of Staphylococcus aureus Bacteraemia (SAB) in Adults","year":"2023"},{"key":"10.1016\/j.clinme.2024.100265_bib0007","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clinme.2024.100265_bib0009","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinme.2024.100265_bib0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.clinme.2024.100265_bib0011","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0012","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.clinme.2024.100265_bib0013","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0014","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/cid\/ciad500","article-title":"Contemporary management of Staphylococcus aureus bacteremia\u2014controversies in clinical practice","volume":"77","author":"Minter","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/antibiotics13020153","article-title":"Clinical effectiveness of continuous infusion flucloxacillin in the outpatient parenteral antimicrobial therapy (OPAT) setting in a UK hospital: a service evaluation","volume":"13","author":"Clarkson","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.clinme.2024.100265_bib0017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"Journal of Infection"},{"key":"10.1016\/j.clinme.2024.100265_bib0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinme.2024.100265_bib0019","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/jac\/dkac047","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015\u201319)","volume":"77","author":"Gilchrist","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinme.2024.100265_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106486","article-title":"Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"59","author":"Yetmar","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.clinme.2024.100265_bib0021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13063-022-06370-1","article-title":"Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial","volume":"23","author":"Turner","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.clinme.2024.100265_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/23744235.2017.1392039","article-title":"Staphylococcus aureus bacteraemia and endocarditis\u2013epidemiology and outcome: a review","volume":"50","author":"Asgeirsson","year":"2018","journal-title":"Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0023","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus network adaptive platform trial protocol: new tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinme.2024.100265_bib0024","first-page":"3487","article-title":"Predictive risk factors for methicillin-resistant Staphylococcus aureus (MRSA) colonisation among adults in acute care settings: a systematic review","volume":"10","author":"Xue","year":"2012","journal-title":"JBI Evidence Synthesis"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824054502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824054502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:47:02Z","timestamp":1732733222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824054502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1470211824054502"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2024.100265","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staphylococcus aureus bacteraemia for the general physician: A narrative review of a metastatic infection with malignant complications","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2024.100265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100265"}}